Limited utility of dried-blood- and plasma spot-based screening for antiretroviral treatment failure with Cobas Ampliprep/TaqMan HIV-1 version 2.0

Journal of Clinical Microbiology

Volumn 52, Issue 11, 2014, Pages 3878-3883

  Sawadogo, Souleymane ^a   Shiningavamwe, Andreas ^b   Chang, Joy ^c   Maher, Andrew D ^a   Zhang, Guoqing ^c   Yang, Chunfu ^c   Gaeb, Esegiel ^b   Kaura, Harold ^b   Ellenberger, Dennis ^c   Lowrance, David W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Namibia Institute of Pathology   (Namibia)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST ACCURACY STUDY; DRIED BLOOD SPOT TESTING; DRIED PLASMA SPOT TESTING; FALSE POSITIVE RESULT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LIMIT OF DETECTION; MALE; PREDICTIVE VALUE; PREVALENCE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; VIRUS LOAD; ADOLESCENT; AGED; BLOOD; DRUG MONITORING; EVALUATION STUDY; GENETICS; HIV INFECTIONS; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MASS SCREENING; MIDDLE AGED; NAMIBIA; PROCEDURES; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-RETROVIRAL AGENTS; BLOOD; DRUG MONITORING; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NAMIBIA; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TREATMENT FAILURE; VIRAL LOAD; YOUNG ADULT;

EID: 84908348400     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02063-14     Document Type: Article

References (28)

1. UNAIDS. 2013. Global update on HIV treatment 2013: results, impact and opportunities. http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2013/20130630-treatment-report-summary-en.pdf.
2. UNAIDS. 2012. Treatment 2015. http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2013/JC2484-treatment-2015-en.pdf.
3. PEPFAR. 2012. PEPFAR blueprint for an AIDS-free generation. http://www.pepfar.gov/documents/organization/201386.pdf.
4. World Health Organization. 2013. The 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. World Health Organization, Geneva, Switzerland.
5. World Health Organization. 2010. The 2010 revision of WHO antiretroviral therapy for HIV infection in adults and adolescents. World Health Organization, Geneva, Switzerland.
6. Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, Goemaere E, de la Vega FG, Perrin L, Rodriguez W. 2007. HIV viral load monitoring in resource-limited regions: optional or necessary? Clin. Infect. Dis. 44:128-134. http://dx.doi.org/10.1086/510073.
7. Stevens WS, Marshall TM. 2010. Challenges in implementing HIV load testing in South Africa. J. Infect. Dis. 201:S78-S84. http://dx.doi.org/10.1086/650383.
8. Mei JV, Alexander JR, Adam BW, Hannon WH 2001. Use of filter paper for the collection and analysis of human whole blood specimens. J. Nutr. 131:S1631-S1636.
9. Brambilla D, Jennings C, Aldrovandi G, Bremer J, Comeau AM, Cassol SA, Dickover R, Jackson JB, Pitt J, Sullivan JL, Butcher A, Grosso L, Reichelderfer P, Fiscus SA. 2003. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J. Clin. Microbiol. 41:1888-1893. http://dx.doi.org/10.1128/JCM.41.5.1888-1893.2003.
10. Johannessen A, Garrido C, Zahonero N, Sandvik L, Naman E, Kivuyo SL, Kasubi MJ, Gundersen SG, Bruun JN, de Mendoza C. 2009. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania. Clin. Infect. Dis. 49:976-981. http://dx.doi.org/10.1086/605502.
11. Garrido C, Zahonero N, Corral A, Arredondo M, Soriano V, de Mendoza C. 2009. Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of NucliSENS EasyQ HIV-1 and real time HIV load tests. J. Clin. Microbiol. 47:1031-1036. http://dx.doi.org/10.1128/JCM.02099-08.
12. Wan H, Seth A, Rainen L, Fernandes H. 2010. Coamplification of HIV-21 proviral DNA and viral RNA in assays used for quantification of HIV-1 RNA. J. Clin. Microbiol. 48:2186-2190. http://dx.doi.org/10.1128/JCM.02034-09.
13. Marconi A, Balestrieri M, Comastri G, Pulvirenti FR, W. Gennari W, Tagliazucchi S, Pecorari M, Borghi V, Marri D, Zazzi M. 2009. Evaluation of the Abbott real-time HIV-1 quantitative assay with dried blood spot specimens. Clin. Microbiol. Infect. 15:93-97. http://dx.doi.org/10.1111/j.1469-0691.2008.02116.x.
14. Namibia Ministry of Health and Social Services.2010. National guidelines for ART, 3rd ed. Namibia.
15. World Health Organization. 2012. WHO Prequalification of Diagnostics Programme, public report the COBAS Ampliprep/COBAS TaqMan (analyzer HIV-1 Test V. 2.0 (Roche)) for HIV-1. World Health Organization, Geneva, Switzerland.
16. Schumacher W, Frick E, Kauselmann M, Maier-Hoyle V, van der Vliet R, Babiel R. 2007. Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS Ampliprep/ COBAS TaqMan system. J. Clin. Virol. 38:304-312. http://dx.doi.org/10.1016/j.jcv.2006.12.022.
17. Ouma KN, Basavaraju SV, Okonji JA, Williamson J, Thomas TK, Mills LA, Nkengasong JN, Zeh C. 2013. Evaluation of quantification of HIV-1 RNA viral load in plasma and dried blood spots by use of the semiautomated Cobas Amplicor assay and the fully automated Cobas Ampliprep/TaqMan assay, version 2.0, in Kisumu, Kenya. J. Clin. Microbiol. 51: 1208-1218. http://dx.doi.org/10.1128/JCM.03048-12.
18. Bland JM, Altman DG. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310.
19. Perez-Gonzalez M. 2013. WHO prequalification of diagnostics update, AMDS Annual Stakeholders and Partners Meeting. World Health Organization, Geneva, Switzerland.
20. Monleau M, Montavon C, Laurent C, Segondy M, Montes B, Delaporte E, Boillot F, Peeters M. 2009. Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing. J. Clin. Microbiol. 47:1107-1118. http://dx.doi.org/10.1128/JCM.02255-08.
21. Waters L, Kambugu A, Tibenderana H, Meya D, John L, Mandalia S, Nabankema M, Namugga I, Quinn TC, Gazzard B, Reynolds SJ, Nelson M. 2007. Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda. J. Acquir. Immune Defic. Syndr. 46:590-593. http://dx.doi.org/10.1097/QAI.0b013e318159d7f4.
22. Marconi A, Balestrieri M, Comastri G, Pulvirenti FR, W. Gennari W, Tagliazucchi S, Pecorari M, Borghi V, Marri D and Zazzi M. 2009. Evaluation of the Abbott real-time HIV-1 quantitative assay with dried blood spot specimens. Clin. Microbiol. Infect. 15:93-97. http://dx.doi.org/10.1111/j.1469-0691.2008.02116.x.
23. Andreotti M, Pirillo M, Guidotti G, Ceffa S, Paturzob G, Germano P, Luhangac R, Chimwaza D, Mancini MG, Marazzi MC, Vella S, Palombi L, Giuliano M. 2010. Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche Cobas TaqMan assay. J. Clin. Virol. 47:4-7. http://dx.doi.org/10.1016/j.jcv.2009.11.006.
24. Johannessen A, Garrido C, Zahonero N, Sandvik L, Naman E, Kivuyo SL, Kasubi MJ, Gundersen SG, Bruun JN, de Mendoza C. 2009. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania, abstr V-136. 16th Conference on Retroviruses and Opportunistic Infections.
25. Ruiz N, Pérez M, Díaz H, Izquierdo M, Blanco M, Machado L, Silva E. 2012. Validation of Cobas Ampliprep/Cobas TaqMan HIV-1 test on dried blood spots. J. Int. AIDS Soc. 15:18192.
26. Liu C, Mauk M, Gross R, Bushman FD, Edelstein PH, Collman RG, Bau HH. 2013. Membrane-based, sedimentation-assisted plasma separator for point-of-care applications. Anal. Chem. 85:10463-10470. http://dx.doi.org/10.1021/ac402459h.
27. Homsy A, van der Wal PD, Doll W, Schaller R, Korsatko S, Ratzer M, Ellmerer M, Pieber TR, Nicol A, de Rooij NF. 2012. Development and validation of a low cost blood filtration element separating plasma from undiluted whole blood. Biomicrofluidics. 6:12804-128049. http://dx.doi.org/10.1063/1.3672188.
28. Yang X, Forouzan O, Brown TP, Shevkoplyas SS. 2012. Integrated separation of blood plasma from whole blood for microfluidic paper-based analytical devices. Lab Chip 12:274-280. http://dx.doi.org/10.1039/c1lc20803a.